AstraZeneca (LSE:AZN) is navigating a period of robust growth and strategic challenges. Recent developments include an 18% ...

AstraZeneca (LON:AZN) has had a rough month with its share price down 9.1%. But if you pay close attention, you ...

AstraZeneca certified as a Best Place to Work for all in Jordan, Lebanon, Iraq, Tunisia, Algeria and Morocco based on ...

Sharma’s analysis would have taken into account AstraZeneca’s financial metrics, market dynamics, and potential for shareholder value creation, leading to his positive outlook on the company’s stock.

Shares in Astrazeneca have plunged as the FTSE 100 company reported mixed results from a late-stage cancer drug trial.

The first Christmas campaigns started in earnest last week, so it must be September. Murdoch makes money moves Rightmove ...

Astrazeneca chief executive Pascal Soriot (pictured) said the company was taking the arrests of eight or nine employees 'very ...

Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...

Two of the simplest ways to measure the success of companies that develop and commercialize drugs is to count their approvals ...

They are more than 7 per cent below last week’s peak. That has trimmed AstraZeneca’s value from £207.5billion to £192.3billion. AstraZeneca last month became the first ever British company ...

I thought the stock looked great value when I bought it earlier this year ... Unfortunately, it isn’t GSK, but rival ...